Target intelligence / Profile preview

Desmocollin-3 (DSC3)

Target
DSC3
Molecular classification
Cell adhesion molecule, Cadherin superfamily, Desmosomal cadherin
01

Overview

Desmocollin-3 is a calcium-dependent transmembrane glycoprotein that belongs to the desmocollin subfamily within the cadherin superfamily. It is one of the principal components of desmosomes—specialized intercellular junctions found primarily in epithelial tissues—which are essential for strong cell–cell adhesion. The protein is expressed mainly in the basal and suprabasal layers of stratified epithelia. Loss or dysfunction of desmocollin-3 impairs cellular adhesion, increases cellular mobility, and can contribute to tumor progression by promoting metastasis. Mutations in its gene (*DSC3*) cause rare inherited disorders such as hypotrichosis with recurrent skin vesicles. Additionally, autoantibodies against desmocollin-3 are implicated in certain autoimmune blistering diseases like pemphigus vulgaris and pemphigus foliaceus; these antibodies disrupt keratinocyte cohesion leading to acantholysis and blister formation. In some cancers—including breast and lung—desmocollin-3 acts as a tumor suppressor by inhibiting pathways such as EGFR/ERK signaling.

Other names
Desmocollin 3DSC3_HUMANCadherin family member 6Previous HGNC symbol: DSC4
02

Biological functions

Cell–cell adhesionFormation and maintenance of desmosomes in epithelial cellsRegulation of epidermal cell positioning (stratification)
03

Disease associations

Cancer (notably breast cancer, lung cancer)Autoimmune skin diseases (pemphigus vulgaris, pemphigus foliaceus)Genetic disorders (hypotrichosis and recurrent skin vesicles)
04

Biomarkers

Biomarker for some cancers, including breast cancer

Beyond the preview

Go deeper on Desmocollin-3 (DSC3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Desmocollin-3 (DSC3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call